Online Programme 2019

18 March 2020
Park Plaza Victoria

Programme

To download the programme as a PDF please click here

08:30 - 10:00

Registration & Refreshments

09:00 - 09:45

Breakfast Briefing: Collaborating to transform the care of cancer patients

  • Understand how you can collaborate to make better use of clinical support services, such as imaging and pathology
  • Discuss the role of Multidisciplinary Diagnostic Centres in supporting early diagnosis
  • Hear an example of successful, sustainable collaboration across trusts to improve service provision

Professor Geoff Bellingan, Executive Lead, UCLH Cancer Collaborative Cancer Alliance
Dr Andrew McCarthy, Clinical Lead, East Midlands Radiology Consortium (EMRAD)

10:00 – 10:15

Chair’s Opening Remarks
Dave West, Deputy Editor, HSJ

10:15 – 11:15

Cancer: Making the long-term plan a reality

  • Hear about the intentions behind the NHS long-term plan for cancer from those responsible for setting and overseeing it
  • Understand what the plan means for you and your role in delivering its aims
  • Consider how to harness the combined efforts of Cancer Alliances, teams and individuals to make the plan a reality

David Fitzgerald, National Cancer Programme Director, NHS England
Professor Sir Mike Richards, National Cancer Director 1999-2013
Roger Spencer, Chief Executive, The Christie FT
Dr Fran Woodard, Executive Director of Policy and Impact, Macmillan Cancer Support

11:15 – 11:45

Morning refreshments and networking

 

Stream A

Chair: Dave West, Deputy Editor, HSJ

Stream B

Chair: Sharon Brennan, Correspondent, HSJ

11:45 – 12:25

Unlocking the benefits of earlier and faster diagnosis

  • Evaluate the impact of screening programmes on early diagnosis and how to increase uptake
  • Learn about a differentiated approach to referrals to support early cancer diagnosis
  • How we can achieve faster diagnosis

Sara Hiom, Director of Early Diagnosis & Health Professional Engagement, Cancer Research UK
Maneesh Madan, Managing Director – Specialist Services, InHealth
Professor Sir Mike Richards, National Cancer Director 1999-2013

Understanding variation in access to care for patients through patient pathway data analysis

  • Why the Secondary Breast Cancer Analytics Project was set up, and the emerging project insights
  • Understand the challenges of working with the available data and how to overcome them
  • What this work means for patients and outcomes

Session sponsored by Novartis Oncology UK

Donna Chung, Head of Centre for Cancer Outcomes, UCLH Cancer Collaborative Cancer Alliance
Stephen Jowett, Country Lead, Health System Engagement, IQVIA
Dominic Wake, Head of Government and NHS Partnership, Novartis Oncology UK
Professor Andrew Wardley, Medical Director, The NIHR Manchester Clinical Research Facility, The Christie FT

12:30 – 13:10

The role of AI in delivering Real Time Information Technology Towards Activation (RITTA)

  • Hear about the Pfizer Oncology UK service projects
  • The Velindre case study: The design and implementation of RITTA
  • Understand the process and considerations for undertaking a collaborative project

Session funded by Pfizer Oncology

Steve Cartwright, Patient Experience Manager, Pfizer Oncology
David Cogan, Patient Speaker
Dr Phil Webb, Associate Director of Planning, Performance and Innovation, Velindre Trust
Clare Webster, Field Operations Manager, Pfizer Oncology

Personalised Medicine & the 100,000 Genomes Project

  • How genomics can improve diagnosis, guide treatment choice, and improve cancer care
  • The impact and implications of the 100,000 Genomes Project on cancer care
  • Implementing personalised medicine through the NHS 10-year plan

Session sponsored by Daiichi-Sankyo UK

Professor Louise Jones, Professor of Breast Pathology, Queen Mary University of London
Dr Manja Meggendorfer, Head of Molecular Genetics, MLL Münchner Leukämielabor GmbH (Munich)

13:10 – 14:10

Lunch and networking

 

Chair: Dave West, Deputy Editor, HSJ

Chair: Sharon Brennan, Correspondent, HSJ

14:10 – 14:50

What is the future role of primary and community care in cancer services?

  • Analyse the role of primary and community care in earlier diagnosis and management of cancer
  • Learn about the role of primary care in screening patients to facilitate earlier diagnosis
  • Find out about the support available from GatewayC to facilitate early cancer diagnosis and improved outcomes
  • Balancing decreasing capacity and the patient's choice of care

Dr Rory Harvey, Chair, East of England Cancer Alliance
Dr Catherine Heaven, Associate Director of the School of Oncology, The Christie FT
Joanne Upton, Lead Cancer Nurse, Lloyds Pharmacy Clinical Homecare

Oncology solutions in practice, from diagnosis to administration: real life case studies

  • Learn about the cutting-edge medical technologies currently in use at different stages of the oncology pathway
  • A glimpse at the roadmap trialing the latest in technology
  • How University Hospitals Birmingham implemented technology and made cost savings and efficiencies
  • How this fits in with the NHSI national report on the provision of aseptic services

Dipak Duggal, Director of Pharmacy, BD
Inderjit Singh, Chief Pharmacist, University Hospitals Birmingham FT

14:55 – 15:35

Bringing lung cancer screening to the patient

  • Hear about work to bring lung cancer screening into the community
  • The evidence of the benefits to patients, as well as to early diagnosis
  • The next steps for improving patient experience of and access to lung screening

Dr Richard Booton, Director of the Manchester Lung Health Check Programme, Manchester University FT
Peter Sharpe, Chief Executive, Cobalt Health
David Wilkins, Head of Diagnostic Imaging, UK & Ireland, Siemens Healthineers

Working in partnership to improve cancer waiting times 

  • The current picture on cancer waiting times
  • How the NHS and private providers can work together to improve patient choice and outcomes
  • Understand the patient experience of using both NHS and private providers

Chris Harrison, Medical Director (Strategy), The Christie FT

Dr Penny Kechagioglou, Chief Medical Officer, GenesisCare, and Clinical Consultant Oncologist, University Hospitals Coventry and Warwickshire Trust 
Joanne Wright, Patient Voice  

15:35 – 16:05

Afternoon refreshments and networking

16:05 – 16:55

What should the cancer workforce of the future look like?

  • Analyse the future cancer workforce that is needed to achieve early diagnosis and intervention priorities
  • Consider the practical steps necessary to ensure there are sufficient staff with the right skills in the cancer workforce
  • Learn about the potential of technology to address the challenges to the future workforce

Dr Richard Roope, Cancer Research UK Senior Clinical Advisor
Laura Roberts, Regional Director (North), Health Education England
Dr Caroline Rubin, Vice President, Faculty of Clinical Radiology, The Royal College of Radiologists
Professor Tony Young, National Clinical Lead for Innovation, NHS England

16:55 – 17:00

Chair’s Closing Remarks
Dave West, Deputy Editor, HSJ

17:00 – 18:00

Networking reception

By continuing to use the site you agree to our cookies policy. Accept